KR20010108331A - 스핑고이드 염기 유도체 및 그의 용도 - Google Patents

스핑고이드 염기 유도체 및 그의 용도 Download PDF

Info

Publication number
KR20010108331A
KR20010108331A KR1020017011411A KR20017011411A KR20010108331A KR 20010108331 A KR20010108331 A KR 20010108331A KR 1020017011411 A KR1020017011411 A KR 1020017011411A KR 20017011411 A KR20017011411 A KR 20017011411A KR 20010108331 A KR20010108331 A KR 20010108331A
Authority
KR
South Korea
Prior art keywords
acid
sphingoid base
sphingoid
base derivative
derivative according
Prior art date
Application number
KR1020017011411A
Other languages
English (en)
Korean (ko)
Inventor
휴고 스트릭스트라
피터 지버트 웨버
Original Assignee
비이체 코이닝
코스모페름 베.파우
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비이체 코이닝, 코스모페름 베.파우 filed Critical 비이체 코이닝
Publication of KR20010108331A publication Critical patent/KR20010108331A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/24Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020017011411A 1999-03-09 2000-03-09 스핑고이드 염기 유도체 및 그의 용도 KR20010108331A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99200700 1999-03-09
EP99200700.5 1999-03-09
PCT/EP2000/002191 WO2000053568A1 (fr) 1999-03-09 2000-03-09 Derives a base sphingoide et leurs utilisations

Publications (1)

Publication Number Publication Date
KR20010108331A true KR20010108331A (ko) 2001-12-07

Family

ID=8239966

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017011411A KR20010108331A (ko) 1999-03-09 2000-03-09 스핑고이드 염기 유도체 및 그의 용도

Country Status (6)

Country Link
EP (1) EP1159256A1 (fr)
JP (1) JP2002539110A (fr)
KR (1) KR20010108331A (fr)
CN (1) CN1360567A (fr)
BR (1) BR0009265A (fr)
WO (1) WO2000053568A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002060405A1 (fr) 2001-01-29 2002-08-08 Cosmoferm B.V. Composition dermatologique veterinaire contenant une base sphingoide et/ou un derive de base sphingoide
EP1287815A1 (fr) * 2001-08-31 2003-03-05 Cosmoferm B.V. Utilisation d'une base sphingoide pour inhiber l'activité de la céramidase
DE60117900D1 (de) * 2001-09-05 2006-05-11 Charmzone Co Phytosphingosinderivate mit Antitumorwirkung
FR2836630B1 (fr) * 2002-03-01 2004-07-09 Lvmh Rech Utilisation cosmetique de la phytosphingosine comme agent amincissant et compositions cosmetiques contenant de la phytosphingosine
US20050143346A1 (en) * 2002-05-02 2005-06-30 Jin-Hee Choi Composition for treating cancer containing n,n-dimethylphytosphingosine
DE10255554A1 (de) 2002-11-28 2004-06-17 Goldschmidt Ag Emulgator-Wachs-Gele auf Wasserbasis
FR2855048B1 (fr) * 2003-05-19 2006-07-21 Oreal Composition comprenant un precurseur de ceramide a base phytosphingosine et un activeur de la voie des 4-hydroxylases, utilisation pour renforcer la fonction barriere de la peau
FR2855049B1 (fr) * 2003-05-19 2006-07-21 Oreal Composition comprenant un precurseur de ceramide a base 6-hydroxy-sphingenine et un activeur de la voie des 6-hydroxylases, utilisation pour renforcer la fonction barriere de la peau
KR101288776B1 (ko) 2011-12-07 2013-07-22 가톨릭대학교 산학협력단 신규한 피토스핑고신 유도체 및 이를 포함하는 염증성 피부질환과 피부과다각화증질환 예방 및 개선용 화장료 조성물
KR20180125171A (ko) * 2016-04-04 2018-11-22 오큐소프트, 인코포레이티드 눈꺼풀 위생을 유지하기 위한 조성물, 키트 및 방법
WO2024201287A1 (fr) 2023-03-27 2024-10-03 Cataya Bio (Shanghai) Co. Production de sels de bases sphingoïdes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
DE69307131T2 (de) * 1992-04-03 1997-04-24 Gist Brocades Nv Selektive n-acylation von aminoalkoholen
EP0691327B1 (fr) * 1993-03-17 1999-07-21 Kao Corporation Derive amine et preparation dermatologique renfermant ce derive
GB2323594A (en) * 1997-03-25 1998-09-30 Victor Martin 2-amino-alkanoic acid derivatives, 2-amino alcohols and diamines
WO1998049999A2 (fr) * 1997-05-02 1998-11-12 Gist-Brocades B.V. Compositions antimicrobiennes destinees a un usage topique

Also Published As

Publication number Publication date
BR0009265A (pt) 2001-11-20
EP1159256A1 (fr) 2001-12-05
CN1360567A (zh) 2002-07-24
WO2000053568A1 (fr) 2000-09-14
JP2002539110A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
JP3533218B2 (ja) 不飽和脂肪族ジカルボン酸
KR100541271B1 (ko) 국소적 사용을 위한 항균조성물
KR20010108331A (ko) 스핑고이드 염기 유도체 및 그의 용도
Sawer et al. The effect of cryptolepine on the morphology and survival of Escherichia coli, Candida albicans and Saccharomyces cerevisiae
US5057320A (en) Means and method for increasing skin respiration
Birkinshaw et al. Studies in the biochemistry of micro-organisms: Fumaryl-dl-alanine (fumaromono-dl-alanide), a metabolic product of Penicillium resticulosum sp. nov
CN112535181B (zh) 一种菊花精油微胶囊及其制备方法和应用
CA1231046A (fr) Composition renfermant de l'imidazolidinyluree et des parabens
US20120208230A1 (en) Em-Lacquer Water Solution Mixed with Natural Component, Method for Preparing Fermented Anti-Oxidant Material Using the Same, and Method for Processing the Material
US5104901A (en) Method of preventing mycoplasma infection
KR20130114808A (ko) 콜라겐 천연 발효액을 포함하는 화장료 조성물
CN114848553B (zh) 一种天然防腐剂及其应用
CN113368001A (zh) 防腐剂的应用与防腐剂组合物及其应用
Subianto et al. Antibacterial potential of butterfly Pea (Clitoria ternatea) towards Aggregatibacter actinomycetemcomitans in vitr
JPH04187618A (ja) 皮膚外用剤
WO1996035439A1 (fr) Extrait a faible poids moleculaire de principes actifs de levures et son procede de preparation
Ahuja et al. Effect of dental films containing amoxycillin and metronidazole on periodontal pathogens: microbiological response
WO2017113263A1 (fr) Nouvelle utilisation de bouillon de fermentation de gluconacetobacter xylinus comme composition cosmétique
KR102227751B1 (ko) 오미자, 백리향 및 꽃향유의 추출 혼합물을 유효성분으로 함유하는 천연 방부대체제 및 이의 용도
US20240082125A1 (en) Use of a short chain fatty acid as antidandruff agent
Razooki et al. A study on Cosmetics Products Marketed in Iraq: Microbiological Aspects
JPH0543445A (ja) 皮膚外用剤
CN113318000A (zh) 化妆品防腐剂及其作为化妆品配方成分的用途
JP3476498B2 (ja) 抗酸化剤および化粧料
CN116172986A (zh) D-柠檬烯在制备抗耐药菌药物中应用

Legal Events

Date Code Title Description
N231 Notification of change of applicant
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid